Impax Asset Management‘s “Impax US Sustainable Economy Fund” released its Q4 2025 investor letter. A copy of the letter can ...

Merck & Co. Inc. MRK on Wednesday announced a strategic collaboration with Mayo Clinic to leverage artificial intelligence ...

Merck posted a modest 2026 outlook that fell short of estimates, as it prepares for some drugs to go off patent later this ...

Advocacy groups from 30 countries are urging Merck to create a global access strategy for its once-a-month HIV prevention ...

Sanofi has replaced chief executive Paul Hudson with the head of German drugmaker Merck KGaA, after the French drugmaker ...

Rochester, Minn.-based Mayo Clinic and pharmaceutical giant Merck are teaming up to leverage AI for drug discovery and development. The partnership will combine data from Mayo Clinic Platform, the ...

Little new information was offered at a public meeting Tuesday evening regarding the ongoing closure of Merck’s Cherokee Plant in Riverside.

Merck reported revenue for the fourth quarter was $16.4 billion, an increase of 5% over the fourth quarter of 2024. For the year the company reported revenue of $65.011 billion, an increase of 1% over ...

Canada's health regulator has approved Merck's new under-the-skin version of its cancer drug Keytruda, offering an alternative to the current intravenous infusion. Health Canada has approved Keytruda ...

Merck (MRK) just reported its fourth quarter and full year 2025 results, pairing higher sales with softer quarterly profit ...

Sanofi has replaced its CEO Paul Hudson after a series of R&D setbacks at the French pharma, handing the reins to Merck KGaA leader Belén Garijo, M.D., Ph.D.

By Atharva Singh and Arasu Kannagi Basil Feb 5 (Reuters) - Drug developer Eikon Therapeutics, headed by Merck veteran Roger ...